TB-500 is a synthetic peptide that mimics the active domain of Thymosin Beta-4 (Tβ4), a highly conserved, water-soluble regenerative protein found in high concentrations within blood platelets and wound fluid. Its primary mechanism of action involves binding to actin—a vital protein responsible for cellular structure and movement. By sequestering actin monomers, TB-500 prevents their polymerization, which dramatically increases the mobility and migration of cells to sites of tissue damage.

Current laboratory and in-vitro applications focus on its robust regenerative properties. Researchers utilize TB-500 to observe its effects on endothelial cell differentiation, the formation of new blood vessels (angiogenesis), and the mitigation of inflammation in soft tissue models. Animal studies frequently highlight its capacity to improve the structural integrity of healing tendons and ligaments, making it a critical compound for research into advanced wound healing and musculoskeletal recovery pathways.